Identification of blood metabolites linked to the risk of cholelithiasis: a comprehensive Mendelian randomization study

被引：0
作者：
Jiarui Mi
Lingjuan Jiang
Zhengye Liu
Xia Wu
Nan Zhao
Yuanzhuo Wang
Xiaoyin Bai
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Graduate School
[2] Peking Union Medical College Hospital,Medical Research Center
[3] Chinese Academy of Medical Science and Peking Union Medical College,Second School of Clinical Medicine
[4] Zhongnan Hospital of Wuhan University,Department of Internal Medicine
[5] Peking Union Medical College Hospital,Department of Clinical Medicine
[6] Peking Union Medical College and Chinese Academy of Medical Sciences,Department of Gastroenterology, Peking Union Medical College Hospital
[7] Peking Union Medical College and Chinese Academy of Medical Sciences,undefined
[8] Peking Union Medical College and Chinese Academy of Medical Sciences,undefined
来源：
Hepatology International | 2022年 / 16卷
关键词：
Mendelian randomization; Metabolites; Risk factor; Cholelithiasis; Sphingomyelin; Fatty acid; Genome-wide association study; Bayesian model; FinnGen Consortium Release; UK Biobank;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1484 / 1493
页数：9
相关论文
共 50 条
  • [31] The relationship between genetic prediction of 486 blood metabolites and the risk of COPD: mendelian randomization study
    Zhang, Yang
    Ma, Xinlai
    Wu, Fan
    Sun, Yuxiao
    Mou, Hongyu
    Liu, Xue
    Zhang, Wei
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Causal relationship between human blood metabolites and risk of ischemic stroke: a Mendelian randomization study
    He, Menghao
    Xu, Chun
    Yang, Renyi
    Liu, Lijuan
    Zhou, Desheng
    Yan, Siyang
    FRONTIERS IN GENETICS, 2024, 15
  • [33] Genetically predicted 486 blood metabolites in relation to risk of esophageal cancer: a Mendelian randomization study
    Jia, Caiyan
    Yi, Dan
    Ma, Mingze
    Xu, Qian
    Ou, Yan
    Kong, Fanming
    Jia, Yingjie
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [34] A stratified study of human blood metabolites and coronary artery diseases-A Mendelian randomization study
    Peng, Mengling
    Fu, Yu
    Qin, Cong
    Shi, Lei
    Zhang, Meiwei
    Zhou, Shanshan
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (01)
  • [35] Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study
    Dong, Hao
    Chen, Rong
    Xu, Fang
    Cheng, Fang
    CLINICAL EPIDEMIOLOGY, 2024, 16 : 131 - 141
  • [36] Blood pressure and risk of cancer: a Mendelian randomization study
    Io Ieong Chan
    Man Ki Kwok
    C. Mary Schooling
    BMC Cancer, 21
  • [37] Causal association between blood metabolites and vertigo: A Mendelian randomization study
    Zhang, Bin
    Chen, Sulan
    Teng, Xin
    Han, Qi
    Wu, Tong
    Liu, Yin
    Xiang, Ke
    Sun, Li
    MEDICINE, 2024, 103 (38)
  • [38] Exploring the mediating role of blood metabolites in the relationship between gut microbiota and gastric cancer risk: a Mendelian randomization study
    Li, Xiaocheng
    Lin, Huapeng
    Peng, Jing
    Gong, Jianping
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2025, 14
  • [39] Blood metabolites mediate the impact of lifestyle factors on the risk of urolithiasis: a multivariate, mediation Mendelian randomization study
    Li, Zhilong
    Wei, Houyi
    Tang, Xiaoyu
    Liu, Tongzu
    Li, Sheng
    Wang, Xinghuan
    UROLITHIASIS, 2024, 52 (01)
  • [40] The causal relationship between human blood metabolites and risk of peripheral artery disease: a Mendelian randomization study
    Dong, Zhiyong
    Wang, Qingyun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
12345